Sculptor Capital’s Lux Health Tech Acquisition Corp. Units LUXAU Stock Holding History

Sculptor Capital’s Portfolio LUXAU Stock Details LUXAU Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q3	–	Sell	-4	Closed	–	–	1306
2022 Q2	$0	Hold	4	–	–	﹤0.01%	1374
2022 Q1	$0	Hold	4	–	–	﹤0.01%	1503
2021 Q4	$0	Buy	+4	New	+$41	﹤0.01%	1324
2021 Q1	–	Sell	-233,800	Closed	-$2.69M	–	866
2020 Q4	$2.69M	Buy	+233,800	New	+$2.51M	0.01%	271

Other funds holding LUXAU

BBR Partners New York $1.79B AUM 16.83% 1-Year Est. Return

HRT Financial New York $40.1B AUM 58.22% 1-Year Est. Return

Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Clear Street New York $24.6B AUM 56.26% 1-Year Est. Return

Ancora Advisors Cleveland, Ohio $4.7B AUM 19.05% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Sculptor Capital's LUXAU Position: Q3 2022 in Review

Sculptor Capital sold out of Lux Health Tech Acquisition Corp. Units (LUXAU) in Q3 2022, closing a stake of 4 shares.

Sculptor Capital first reported a position in LUXAU in Q4 2020 and held it in 4 quarters. The position peaked at $2.69M in Q4 2020. 9 funds tracked by Wall St. Rank hold LUXAU as of Q3 2022.

Sculptor Capital reported no remaining Lux Health Tech Acquisition Corp. Units position as of Q3 2022 after selling out during the quarter.
Sculptor Capital sold 4 Lux Health Tech Acquisition Corp. Units shares in Q3 2022.
Sculptor Capital first reported a position in Lux Health Tech Acquisition Corp. Units in Q4 2020 and held it in 4 quarters.
Sculptor Capital's Lux Health Tech Acquisition Corp. Units position peaked at $2.69M in Q4 2020.
9 funds tracked by Wall St. Rank held Lux Health Tech Acquisition Corp. Units as of Q3 2022.

Based on Sculptor Capital's 13F filing for Q3 2022, filed 14 Nov 2022.